Barter trade is still practiced in Abotoase market in the Oti region, where locals exchange farm produce like maize and ...

The three staple crops dominating modern diets – corn, rice and wheat – are familiar to Americans. However, fourth place is held by a dark horse: cassava. While nearly unknown in temperate climates, ...

For most of his career, P’damore has been an independent artiste who has recorded songs for independent producers in Jamaica ...

Be it from Senegal, Gambia, Ghana, or Nigeria, West African food has existed in the capital for decades and the range of ...

Investors with a lot of money to spend have taken a bearish stance on Cassava Sciences SAVA. And retail traders should know. We noticed this today when the trades showed up on publicly available ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Alzheimer’s drug developer Cassava Sciences agreed Thursday to pay $40 million to settle regulatory claims that it misled investors about the results of a clinical trial that showed promise for ...

Cassava Sciences and its executives agreed to pay $40 million in penalties for misleading investors. Dr. Wang, a consultant, manipulated clinical trial data, leading to misleading Alzheimer's ...

Shares of Cassava Sciences Inc. dropped more than 12% in the extended session Thursday U.S. securities regulators announced a settlement with the pharma company, after charging it and two former ...

For nearly a year, my stance on Cassava Sciences and its Alzheimer’s disease drug candidate simufilam has been clear: Emerging evidence shows the drug is inert, and patients with Alzheimer’s ...

Shares of Cassava Sciences Inc. dropped more than 12% in the extended session Thursday after announcing a settlement with U.S. securities regulators, who had charged the pharma company and two ...

Alzheimer's drug developer Cassava Sciences (NASDAQ:SAVA) has struck a consulting agreement with its former chief executive officer, Remi Barbier, nearly two months after his resignation.